Wolff H, Naundorf M
Klinik für Chirurgie, Medizinischen Fakultät (Charité), Humboldt-Universität zu Berlin.
Zentralbl Chir. 1991;116(1):3-13.
In this paper we report about the treatment process of thymic tumours. Dominating among our patients are thymomas with lymphocyte predominance (n = 16) followed by epithelioid (n = 8) and spindle cell (n = 2) thymomas. For classification and for estimation of prognosis all thymomas were divided into macroscopical and histological stadiums I-IV. In the long-term process a better survival rate for patients with thymomas with lymphocyte predominance and histological stadium of invasion I was 93% over seven years. The worst results were reached by patients of the infiltration groups III and IV-the survival rate was 50%. By 17 of 26 patients suffering from a thymoma the tumours were associated with myasthenia gravis. Especially frequently we found class IIB and III according to Osserman. The survival rate in this patients was 76.5% (13 patients) in the treatment process. An improvement and stabilization of myasthenia gravis was possible for 13 patients. If the complete removal is limited by the growth of the tumor and by the infiltration rate, the further additional therapy--radiation therapy and polychemotherapy--will help to improve the prognosis.
在本文中,我们报告了胸腺肿瘤的治疗过程。在我们的患者中,以淋巴细胞为主型胸腺瘤占主导(n = 16),其次是上皮样胸腺瘤(n = 8)和梭形细胞胸腺瘤(n = 2)。为了进行分类和评估预后,所有胸腺瘤都被分为宏观和组织学I-IV期。在长期过程中,淋巴细胞为主型胸腺瘤且组织学浸润I期的患者7年生存率较好,为93%。浸润III期和IV期的患者结果最差,生存率为50%。26例胸腺瘤患者中有17例肿瘤与重症肌无力相关。根据 Osserman 分类,我们特别频繁地发现 IIB 级和 III 级。在治疗过程中,这些患者的生存率为76.5%(13例患者)。13例患者的重症肌无力病情得到改善和稳定。如果肿瘤的生长和浸润率限制了完全切除,进一步的辅助治疗——放射治疗和多药化疗——将有助于改善预后。